Related Experiment Video
Updated: Aug 13, 2026
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
Noninvasive diagnosis of allograft vascular disease after heart transplantation
F Bacal1, N A Stolf, V C Veiga
1Instituto do Coração do Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, 05403-000, Brazil.
Insights
Noninvasive tests can detect allograft vascular disease. Combining dobutamine echocardiography and thallium scintigraphy offers a promising approach for early detection in asymptomatic patients.
Area of Science:
- Cardiology
- Transplant Medicine
- Diagnostic Imaging
Background:
- Allograft vascular disease (AVD) is a significant complication after organ transplantation.
- Early detection of AVD is crucial for patient outcomes.
- Noninvasive diagnostic methods are needed to assess AVD risk.
Purpose of the Study:
- To evaluate the predictive values of various noninvasive tests for detecting allograft vascular disease.
- To compare the diagnostic accuracy of Holter monitoring, thallium scintigraphy, treadmill stress test, and dobutamine stress echocardiography against cine-coronary arteriography.
Main Methods:
- 39 patients with a mean age of 48 years and 86-month follow-up were studied.
- Allograft vascular disease diagnosis was confirmed by cine-coronary arteriography (>50% lumen obstruction).
- Patients underwent Holter monitoring, thallium scintigraphy, treadmill stress test, and dobutamine stress echocardiography.
Main Results:
- Allograft vascular disease was present in 38% of patients.
- Dobutamine stress echocardiography showed 63.6% sensitivity and 91.3% specificity.
- Combining dobutamine echocardiography with thallium scintigraphy yielded 71.4% sensitivity and 87% specificity.
Conclusions:
- The combination of dobutamine echocardiography and thallium scintigraphy demonstrates good predictive value for AVD detection.
- This combined noninvasive approach may be a valuable tool for screening asymptomatic transplant recipients.
- Further research can validate these findings in larger, diverse patient cohorts.
Objective:
To determine the predictive values of noninvasive tests for the detection of allograft vascular disease.
Methods:
We studied 39 patients with mean ages of 48+/-13 years and a follow-up period of 86+/-13 months. The diagnosis of allograft vascular disease was made by cine-coronary arteriography, and it was considered as positive if lesions existed that caused > or =50% obstruction of the lumen. Patients underwent 24h Holter monitoring, thallium scintigraphy, a treadmill stress test, and dobutamine stress echocardiography. Sensitivity, specificity, and positive and negative predictive values were determined in percentages for each method, as compared with the cine-coronary arteriography results.
Results:
Allograft vascular disease was found in 15 (38%) patients. The Holter test showed 15.4% sensitivity, 95.5% specificity. For the treadmill stress test, sensitivity was 10%, specificity was 100%. When thallium scintigraphy was used, sensitivity was 40%, specificity 95.8%. On echocardiography with dobutamine, we found a 63.6% sensitivity, 91.3% specificity. When the dobutamine echocardiogram was associated with scintigraphy, sensitivity was 71.4%, specificity was 87%.
Conclusion:
In this group of patients, the combination of two noninvasive methods (dobutamine echocardiography and thallium scintigraphy) may be a good alternative for the detection of allograft vascular disease in asymptomatic patients with normal ventricular function.
